CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Ticker
- SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 15-12G Other 15-12G
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 775 shares at $35.39 ($27,429)
- 4 Open-market buy Director bought 1,771 shares at $35.39 ($62,680)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 29 · 572 filings